Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3-di(n-butyl)aminopropanol Hcl
2. Halfan
3. Halofantrine
4. Wr 171,699
5. Wr 171669
6. Wr-171,669
7. Wr-171699
1. 36167-63-2
2. Halfan
3. Halofantrine Hcl
4. Halofantrine Hydrochloride [usan]
5. Wr-171669
6. Skf-102886
7. Halofantrine (hydrochloride)
8. 3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol;hydrochloride
9. (-)-halofantrine Hydrochloride
10. 2b7enl644k
11. 106927-11-1
12. Halofantrine Hydrochloride, (-)-
13. H77dl0y630
14. 3-(dibutylamino)-1-(1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl)propan-1-ol Hydrochloride
15. 9-(3-(dibutylamino)-1-hydroxypropyl)-1,3-dichloro-6-(trifluoromethyl)phenanthrene Hydrochloride
16. Dl-wr 171669
17. Ncgc00016833-01
18. Skf-102886;wr-171669
19. Dsstox_cid_25464
20. Dsstox_rid_80895
21. Dsstox_gsid_45464
22. Halofantrine Hydrochloride (usan)
23. Halofantrino
24. Halofantrino [spanish]
25. Mls002154111
26. 66051-64-7
27. Cas-36167-63-2
28. (+-)-halofantrine Hydrochloride
29. Wr 171669
30. Wr-171,669
31. Smr001233418
32. Einecs 252-895-4
33. Unii-h77dl0y630
34. Halfan (tn)
35. Mfcd00879136
36. Skf 102886
37. Halofantrine Hydrochlorid
38. 1,3-dichloro-6-trifluoromethyl-9-(3-(dibutylamino)-1-hydroxypropyl)phenanthrene Hcl
39. 1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3-(di-n-butylamino)propanol Hydrochloride
40. Unii-2b7enl644k
41. 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-9-phenanthrenemethanol Hydrochloride
42. Schembl466895
43. Chembl1200901
44. Dtxsid0045464
45. Hy-a0148a
46. Hms1571o03
47. Tox21_110637
48. Akos030254762
49. Tox21_110637_1
50. Ccg-221031
51. Halofantrine Hydrochloride [mi]
52. Sk&f-102866
53. Ncgc00179250-03
54. (+/-)-halofantrine Hydrochloride
55. 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)phenanthren-1-methanol Hydrochloride
56. 9-phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride
57. Halofantrine Hydrochloride [mart.]
58. Halofantrine Hydrochloride [vandf]
59. Halofantrine Hydrochloride [who-dd]
60. Cs-0031225
61. Ft-0600399
62. D02485
63. Halofantrine Hydrochloride [ep Impurity]
64. Halofantrine Hydrochloride [orange Book]
65. Halofantrine Hydrochloride [ep Monograph]
66. 167h632
67. Halofantrine Hydrochloride, >=98% (hplc), Solid
68. Sr-01000841216
69. Sr-01000841216-2
70. W-106636
71. Halofantrine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
72. 1-[1,3-dichloro-6-trifluoromethyl-9-phenanthryl]-3-di(n-butyl)aminopropanol Hydrochloride
73. 1,3-dichloro-.alpha.-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-9-phenanthrenemethanol Hydrochloride
74. 1,3-dichloro-alpha-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-9-phenanthrenemethanol;(+/-)-halofantrine Hydrochloride
75. 9-phenanthrenemethanol, 1,3-dichloro-.alpha.-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride
76. 9-phenanthrenemethanol, 1,3-dichloro-.alpha.-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride (1:1)
77. 9-phenanthrenemethanol, 1,3-dichloro-.alpha.-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride, (-)-
78. 9-phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride, (-)-
Molecular Weight | 536.9 g/mol |
---|---|
Molecular Formula | C26H31Cl3F3NO |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 10 |
Exact Mass | 535.142332 g/mol |
Monoisotopic Mass | 535.142332 g/mol |
Topological Polar Surface Area | 23.5 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 584 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antimalarials
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Halofantrine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Halofantrine Hydrochloride, including repackagers and relabelers. The FDA regulates Halofantrine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Halofantrine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Halofantrine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Halofantrine Hydrochloride supplier is an individual or a company that provides Halofantrine Hydrochloride active pharmaceutical ingredient (API) or Halofantrine Hydrochloride finished formulations upon request. The Halofantrine Hydrochloride suppliers may include Halofantrine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Halofantrine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Halofantrine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Halofantrine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Halofantrine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Halofantrine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Halofantrine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Halofantrine Hydrochloride suppliers with NDC on PharmaCompass.
Halofantrine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Halofantrine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Halofantrine Hydrochloride GMP manufacturer or Halofantrine Hydrochloride GMP API supplier for your needs.
A Halofantrine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Halofantrine Hydrochloride's compliance with Halofantrine Hydrochloride specifications and serves as a tool for batch-level quality control.
Halofantrine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Halofantrine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Halofantrine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Halofantrine Hydrochloride EP), Halofantrine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Halofantrine Hydrochloride USP).
LOOKING FOR A SUPPLIER?